drugset / Trial / NCT05538949
Safety, Tolerability and Pharmacokinetics of EB-203 Eye Drops in Healthy Volunteers
RandomizedSequentialQuadruple-blindTreatment
Summary
The purpose of study is to evaluate safety, tolerability and pharmacokinetics of EB-203 Drops in adult healthy volunteers. condition/disease : AMD(Age-related Macular Degeneration) Intervention/treatment : EB-203 or Placebo Phase : Phase I
Timeline
- Start
- 2022-06-29
- Primary completion
- 2022-10-07
- Completion
- 2022-10-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | EB-203 | Unknown | 1 % | Other |
| Subject | EB-203 | Unknown | 2 % | Other |
| Subject | EB-203 | Unknown | 4 % | Other |
| Subject | EB-203 | Unknown | 8 % | Other |
Indications
No indication recorded.